InvestorsHub Logo
Followers 251
Posts 13641
Boards Moderated 0
Alias Born 05/19/2015

Re: joe botts post# 113188

Tuesday, 09/06/2022 8:14:17 PM

Tuesday, September 06, 2022 8:14:17 PM

Post# of 118380
Can we get a mod to put the truth of the zero debt as of July 19th and The Company recognized Net Income of $66,958,167 during the quarter ended June 30, 2022 that Counters all the old outdated debt in the intro.
So others are not misinformed!

On July 19, 2022 Regen Biopharma, Inc. (the “Company”) issued 54,514,492 common shares (“Shares”) to Coventry Enterprises LLC in satisfaction of $180,552 of convertible indebtedness. The principal balance and accrued interest payable remaining on the $1,500,000 promissory note issued to Coventry Enterprises LLC are both $0 as of July 19,2022.

https://docoh.com/search?q=0001589150
On no recognized income Zero debt!
The Company recognized Net Income of $66,958,167 during the quarter ended June 30, 2022
There’s a big difference between Derivative Liability and debt.
It looks like the recognized $66 million Net income took care of the very small debt and Derivative Liability LoL!
LOL SLAM DUNK! Outdated MISINFORMATION PROVEN WRONG AGAIN!